Table 2. List of CHR4 Interacting Proteins.
| Gene ID | Name | SAMs with Younger Leaves at 5w-SD-Stage | |||
|---|---|---|---|---|---|
| No. of Unique Peptides (IP1-IP2-IP3) | Sequence Coverage (%) (IP1-IP2-IP3) | Log2 Ratio | P-Value | ||
| AT5G44800 | CHR4 | 142 (128-130-114) | 59.6 (55.2-55.9-53.7) | 10.41 | 1.43e-05 |
| Transcription factors | |||||
| AT1G69120 | AP1 | — | — | — | — |
| AT5G20240 | PI | — | — | — | — |
| AT3G54340 | AP3 | — | — | — | — |
| AT5G15800 | SEP1 | — | — | — | — |
| AT3G02310 | SEP2 | — | — | — | — |
| AT2G45650 | AGL6 | — | — | — | — |
| AT2G42830 | SHP2 | — | — | — | — |
| AT3G13960 | GRF5 | 7 (6-5-4) | 18.1 (15.9-13.9-9.6) | 6.05 | 2.16e-04 |
| AT4G37740 | GRF2 | 6 (6-5-3) | 17.4 (17.4-15.3-9.5) | 5.19 | 1.90e-05 |
| AT5G43270 | SPL2 | — | — | — | — |
| AT1G02065 | SPL8 | — | — | — | — |
| AT1G27360 | SPL11 | — | — | — | — |
| AT5G50670 | SPL13 | 5 (5-4-2) | 19.2 (19.2-15-6.7) | 4.84 | 2.20e-03 |
| AT2G28550 | TOE1 | 5 (5-5-3) | 15.4 (15.4-15.4-8.7) | 4.01 | 1.89e-03 |
| AT3G02150 | TCP13 | 5 (4-4-3) | 18 (18-18-10.4) | 4.21 | 2.20e-02 |
| Chromatin remodeler | |||||
| AT2G46020 | BRM | 37 (30-31-16) | 24.2 (19.3-19.7-10.8) | 2.68 | 8.95e-04 |
| AT1G08600 | ATRX | 23 (19-22-6) | 13.9 (11.7-13.3-5.5) | 5.23 | 9.14e-05 |
| AT5G04240 | ELF6 | 10 (8-10-1) | 11.7 (7.8-11.7-0.8) | 3.09 | 2.20e-03 |
| AT2G28290 | SYD | 27 (21-21-15) | 11.1 (7.9-7.9-5.9) | 3.09 | 1.19e-03 |
| AT2G25170 | PKL | 19 (17-17-14) | 19.8 (16.7-17.4-14.8) | 2.71 | 5.48e-04 |
| AT3G12810 | PIE1 | 18 (14-15-9) | 11.5 (9.9-9.8-6.8) | 3.23 | 6.26e-03 |
| AT5G18620 | CHR17 | 17 (15-15-8) | 44.1 (42.4-42.4-25.3) | 2.85 | 5.34e-04 |
| AT3G06400 | CHR11 | 12 (11-10-10) | 45.1 (41.9-41.7-30.3) | 2.90 | 6.86e-04 |
| AT3G48430 | REF6 | 27 (22-25-18) | 23.4 (18.8-21-17) | 2.92 | 2.49e-03 |
| AT5G11530 | EMF1 | 10 (7-8-3) | 10.4 (6.9-8.3-3.5) | 5.12 | 1.12e-04 |
| AT2G06210 | ELF8 | 14 (12-13-9) | 15.9 (11.8-13.6-11.2) | 2.72 | 2.50e-03 |
| AT5G53430 | SDG29 | 5 (4-5-2) | 8 (7-8-4.5) | 4.40 | 8.19e-03 |
| AT4G02020 | SWN | 3 (2-1-2) | 4.8 (3-1.3-3) | 2.40 | 5.04e-03 |
| General transcriptional coregulators | |||||
| AT3G07780 | OBE1 | 14 (13-13-8) | 31.3 (29.7-31.3-20.8) | 6.47 | 7.02e-05 |
| AT5G48160 | OBE2 | 23 (21-17-9) | 41.5 (40.8-30.1-19.3) | 5.16 | 3.03e-03 |
| AT1G15750 | TPL | 12 (11-10-9) | 31.7 (27-26.9-24.4) | 3.93 | 3.17e-04 |
| AT1G80490 | TPR1 | 9 (8-7-6) | 25.4 (23.6-22.5-17.5) | 4.59 | 2.03e-03 |
| AT3G16830 | TPR2 | 8 (7-6-4) | 13.5 (12.6-10.2-5.1) | 3.57 | 1.99e-02 |
| AT2G32950 | COP1 | 7 (6-7-2) | 12.7 (11.7-12.7-4.3) | 3.99 | 4.02e-03 |
| AT2G46340 | SPA1 | 10 (7-10-3) | 13.2 (9.2-13.2-3.6) | 2.72 | 3.80e-02 |
| AT1G43850 | SEU | 12 (11-10-6) | 18.1 (16.9-12.9-9.9) | 3.69 | 2.49e-03 |
| Inflorescence under LDs | |||||
| AT5G44800 | CHR4 | 117 (114-99-114) | 51.4 (51.4-49.7-51.2) | 8.76 | 1.09e-04 |
| Transcription factors | |||||
| AT1G69120 | AP1 | 12 (8-3-7) | 34 (21.5-10.2-24.2) | 3.55 | 1.24e-02 |
| AT5G20240 | PI | 8 (6-3-8) | 31.7 (25.5-11.5-31.7) | 6.31 | 3.36e-03 |
| AT3G54340 | AP3 | 7 (7-5-7) | 31.5 (31.5-19-31.5) | 4.56 | 4.63e-02 |
| AT5G15800 | SEP1 | 2 (2-1-2) | 23.5 (23.5-17.1-21.9) | 4.06 | 2.63e-02 |
| AT3G02310 | SEP2 | 3 (2-1-2) | 32.8 (23.6-17.2-22) | 4.05 | 4.47e-03 |
| AT2G45650 | AGL6 | 3 (3-2-3) | 10.3 (10.3-10.3-10.3) | 3.78 | 9.16e-03 |
| AT2G42830 | SHP2 | 4 (4-3-4) | 29.3 (29.3-24-29.3) | 4.88 | 6.01e-03 |
| AT3G13960 | GRF5 | 4 (3-3-4) | 13.6 (9.1-9.1-13.6) | 3.62 | 3.28e-02 |
| AT4G37740 | GRF2 | 1 (1-1-1) | 3.2 (3.2-3.2-3.2) | 1.39 | 2.17e-01 |
| AT5G43270 | SPL2 | 4 (4-4-4) | 17.2 (17.2-17.2-17.2) | 5.30 | 3.32e-03 |
| AT1G02065 | SPL8 | 4 (4-2-4) | 18.3 (18.3-12-18.3) | 3.93 | 1.40e-02 |
| AT1G27360 | SPL11 | 8 (5-2-7) | 27 (17.8-10.2-21.9) | 5.57 | 1.53e-03 |
| AT5G50670 | SPL13 | 4 (3-1-4) | 13.9 (11.1-3.1-13.9) | 3.68 | 4.96e-03 |
| AT2G28550 | TOE1 | — | — | — | — |
| AT3G02150 | TCP13 | 6 (5-3-5) | 18.3 (15.5-10.1-15.5) | 3.96 | 5.85e-03 |
| Chromatin remodeler | |||||
| AT2G46020 | BRM | 24 (13-12-18) | 13 (8.6-8.4-10) | 2.57 | 2.36e-02 |
| AT1G08600 | ATRX | 28 (20-18-24) | 18.3 (13.8-13.3-16.3) | 4.64 | 2.59e-03 |
| AT5G04240 | ELF6 | 4 (4-1-4) | 5.8 (5.8-0.7-5.8) | 2.63 | 5.22e-02 |
| AT2G28290 | SYD | 21 (19-12-20) | 8 (7.6-4.6-8) | 3.70 | 4.76e-02 |
| AT2G25170 | PKL | 26 (23-18-24) | 23.6 (23-17.4-20.9) | 3.49 | 1.38e-02 |
| AT3G12810 | PIE1 | 7 (4-3-6) | 4.5 (3.2-2.6-4.1) | 1.89 | 1.04e-01 |
| AT5G18620 | CHR17 | 14 (11-13-12) | 37.4 (35.6-32.6-37.2) | 2.97 | 1.49e-02 |
| AT3G06400 | CHR11 | 17 (13-9-14) | 41.3 (39.2-32-39.1) | 2.34 | 9.72e-03 |
| AT3G48430 | REF6 | 33 (27-17-29) | 28.8 (24.8-12.9-24.5) | 2.21 | 1.39e-02 |
| AT5G11530 | EMF1 | 7 (6-3-7) | 8.5 (7.8-2.9-8.5) | 3.31 | 1.96e-02 |
| AT2G06210 | ELF8 | — | — | — | — |
| AT5G53430 | SDG29 | 7 (4-1-5) | 10.6 (7-2.5-7.2) | 1.99 | 3.08e-02 |
| AT4G02020 | SWN | 3 (2-2-2) | 4.2 (2.5-2.5-2.5) | 1.52 | 3.13e-02 |
| General transcriptional coregulators | |||||
| AT3G07780 | OBE1 | 12 (7-6-8) | 26 (17.8-14.7-20.7) | 4.12 | 3.47e-03 |
| AT5G48160 | OBE2 | 11 (9-5-11) | 26.3 (21.3-12.9-26.3) | 3.73 | 6.56e-03 |
| AT1G15750 | TPL | — | — | — | — |
| AT1G80490 | TPR1 | — | — | — | — |
| AT3G16830 | TPR2 | — | — | — | — |
| AT2G32950 | COP1 | 4 (3-3-3) | 6.7 (5.6-5.6-5.6) | 1.17 | 1.63e-01 |
| AT2G46340 | SPA1 | 3 (1-1-2) | 4.4 (1.4-1.4-2.6) | 1.75 | 9.65e-03 |
| AT1G43850 | SEU | 7 (6-2-6) | 9.8 (9.7-3.6-8.6) | 3.55 | 2.64e-03 |
Dashes indicate no data.